Background** This review is awaiting update with a new protocol. The methods used for the
review were acceptable when the review was published but do not meet contemporary …

Background Alzheimer's disease is the commonest cause of dementia affecting older
people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of …

Background—Cerebrovascular disease (CVD) and ischemic brain injury secondary to
cardiovascular disease are common causes of dementia and cognitive decline in the …

Background/Objectives To examine the comparative effectiveness and safety of cognitive
enhancers for Alzheimer's disease (AD). Design Systematic review and Bayesian network …

Objectives: Randomised controlled trials that directly compare cholinesterase inhibitors for
the treatment of Alzheimer's disease have been characterised by significant methodological …

Alzheimer's disease is the most common form of dementia in industrialized countries. In the
European Union, about 54% of dementia cases are believed to be due to Alzheimer's …

Background Vascular dementia represents the second most common type of dementia after
that caused by Alzheimer's disease. Particularly in older patients, the combination of …

Objective: The aim was to evaluate the efficacy, safety and tolerability of rivastigmine
capsules in patients diagnosed with probable vascular dementia (VaD). Methods: VantagE …

The third edition of this successful textbook has been completely updated throughout and
includes new chapters on electrophysiological tests, biological markers, global staging …

Cerebrovascular disease (CVD), as well as secondary ischemic brain injury from
cardiovascular disease, are common causes of dementia and cognitive decline in the …